1. From the Editor

   EditorialNotes 13 November 2012 Pages: 1 - 1

2. Why a Journal of Pharmacoeconomics?

   • John M. Eisenberg

   Guest Editorial 13 November 2012 Pages: 2 - 4

3. The Changing Healthcare Environment

   • David B. Evans

   Guest Editorial 13 November 2012 Pages: 5 - 7

4. Economic Evaluation of Pharmaceuticals

   • Michael F. Drummond

   Leading Article 13 November 2012 Pages: 8 - 13

5. Economic Evaluation of Drugs

   • Nicholas Wells

   Leading Article 13 November 2012 Pages: 14 - 19

6. Principles of Pharmacoeconomic Analysis of Drug Therapy

   • Deborah A. Freund
   • Robert S. Dittus

   Review Article 13 November 2012 Pages: 20 - 29

7. Taxonomy of Pharmacoeconomics

   • D. A. Freund
   • R. S. Dittus

   Guide Chart 13 November 2012 Pages: 30 - 31

8. Pharmacoeconomic Evaluation of Risk Factors for Cardiovascular Disease

   • Astrid E. Fletcher
   • Christopher J. Bulpitt

   Review Article 13 November 2012 Pages: 33 - 44

9. Pharmacoeconomics of Genetically Engineered Drugs

   • Amy J. Jones-Grizzle
   • J. Lyle Bootman

   Review Article 13 November 2012 Pages: 45 - 53

10. Economic Analysis as an Aid to Subsidisation Decisions

    • David Henry

    Review Article 13 November 2012 Pages: 54 - 67

11. Idarubicin More Cost-Effective than Daunorubicin?

    • Alan L. Hillman

    Current Comment 13 November 2012 Pages: 68 - 69

12. Economic Cost of Asthma Substantial in NSW

    • Douglas Coyle

    Current Comment 13 November 2012 Pages: 69 - 70

13. Total Costs of HIV Disease Higher with Zidovudine?

    • Stephen T. Chambers

    Current Comment 13 November 2012 Pages: 70 - 71